Cointime

Advitech

company

About

Advitech researches, develops, and commercializes nutraceutical ingredients and products to prevent immune-mediated inflammatory disorders.

  • 11 - 50

Highlights

Total Funding Amount
$2.51M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$2.51M
Industries
Biotechnology,Developer Platform,Nutraceutical
Founded date
Jan 1, 1997
Number Of Employee
11 - 50
Operating Status
Active

Advitech is a life science and technology company with the mission to discover and commercialize patented, scientifically supported natural health products. Effective and safe, these products target immune system disorders, such as psoriasis and inflammatory bowel disease. Advitech produces Dermylex (R) for the treatment of mild to moderate psoriasis. Advitech has developed a research program to develop new applications in the field of wound healing. This development program stems from the two technological platforms XP-828L and IM.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$2.51M
Advitech has raised a total of $2.51M in funding over 2 rounds. Their latest funding was raised on Nov 26, 2009 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 26, 2009 Series Unknown $2.51M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Advitech is funded by 1 investors. AgeChem Venture Fund are the most recent investors.
Investor Name Lead Investor Funding Round
AgeChem Venture Fund — Series Unknown
Cointime
Содержание
компания